IGF1 and diabetic kidney disease: Studies have shown that TECs are specific targets for insulin or IGF, and epithelial cell‐specific insulin signal transduction is biologically important for normal glomerular function and DKD.41 IGFBPs can enhance or inhibit the biological effect of IGF by regulating the binding of IGF to its specific receptor.